Re-evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients

Clin Endocrinol (Oxf). 2005 Oct;63(4):477-8. doi: 10.1111/j.1365-2265.2005.02329.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acromegaly / blood
  • Acromegaly / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Cabergoline
  • Dopamine Agonists / therapeutic use*
  • Drug Therapy, Combination
  • Ergolines / therapeutic use*
  • Female
  • Humans
  • Insulin-Like Growth Factor I / analysis
  • Male
  • Middle Aged
  • Octreotide / therapeutic use*

Substances

  • Antineoplastic Agents
  • Dopamine Agonists
  • Ergolines
  • Insulin-Like Growth Factor I
  • Cabergoline
  • Octreotide